1. Home
  2. AERT vs NRSN Comparison

AERT vs NRSN Comparison

Compare AERT & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AERT
  • NRSN
  • Stock Information
  • Founded
  • AERT 2012
  • NRSN 2017
  • Country
  • AERT Singapore
  • NRSN Israel
  • Employees
  • AERT N/A
  • NRSN N/A
  • Industry
  • AERT Professional Services
  • NRSN Biotechnology: Pharmaceutical Preparations
  • Sector
  • AERT Consumer Discretionary
  • NRSN Health Care
  • Exchange
  • AERT Nasdaq
  • NRSN Nasdaq
  • Market Cap
  • AERT 31.3M
  • NRSN 29.8M
  • IPO Year
  • AERT N/A
  • NRSN 2021
  • Fundamental
  • Price
  • AERT $0.59
  • NRSN $1.04
  • Analyst Decision
  • AERT
  • NRSN Buy
  • Analyst Count
  • AERT 0
  • NRSN 2
  • Target Price
  • AERT N/A
  • NRSN $14.00
  • AVG Volume (30 Days)
  • AERT 906.6K
  • NRSN 192.2K
  • Earning Date
  • AERT 11-10-2025
  • NRSN 12-17-2025
  • Dividend Yield
  • AERT N/A
  • NRSN N/A
  • EPS Growth
  • AERT N/A
  • NRSN N/A
  • EPS
  • AERT N/A
  • NRSN N/A
  • Revenue
  • AERT $69,346,000.00
  • NRSN N/A
  • Revenue This Year
  • AERT N/A
  • NRSN N/A
  • Revenue Next Year
  • AERT N/A
  • NRSN N/A
  • P/E Ratio
  • AERT N/A
  • NRSN N/A
  • Revenue Growth
  • AERT N/A
  • NRSN N/A
  • 52 Week Low
  • AERT $0.46
  • NRSN $0.80
  • 52 Week High
  • AERT $2.67
  • NRSN $2.60
  • Technical
  • Relative Strength Index (RSI)
  • AERT 50.78
  • NRSN 46.64
  • Support Level
  • AERT $0.55
  • NRSN $0.89
  • Resistance Level
  • AERT $0.68
  • NRSN $0.97
  • Average True Range (ATR)
  • AERT 0.06
  • NRSN 0.07
  • MACD
  • AERT 0.00
  • NRSN -0.00
  • Stochastic Oscillator
  • AERT 39.79
  • NRSN 60.74

About AERT Aeries Technology Inc.

Aeries Technology Inc is a professional and management services partner offering a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client's business operations. It supports and drives its client's growth across the globe by providing a range of management consultancy services involving professional advisory services and operations management services to build and manage dedicated delivery centers in appropriate locations based on customer business needs.

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Share on Social Networks: